• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Bova评分、简化肺栓塞严重性指数(sPESI)和卡纳德利(Qanadli)评分在急性肺栓塞患者中的预后评估效能

Prognostic performance of the Bova, sPESI, and Qanadli scores in patients with acute pulmonary embolism.

作者信息

Korkut Mustafa, Yavuz Alpaslan, Selvi Fatih, Zortuk Ökkeş, İnan Erdinç Hakan, Güven Hasan Can

机构信息

Department of Emergency Medicine, Health Science University Antalya Training and Research Hospital, Antalya, Turkey.

Department of Radiology, Health Science University Antalya Training and Research Hospital, Antalya, Turkey.

出版信息

Acta Radiol. 2024 Dec;65(12):1482-1490. doi: 10.1177/02841851241289693. Epub 2024 Oct 24.

DOI:10.1177/02841851241289693
PMID:39449365
Abstract

BACKGROUND

Acute pulmonary embolism (PE) is a disease with a serious prognosis and a high probability of death in the emergency department.

PURPOSE

To investigate the prediction of PE-related mortality and intensive care admission (ICU) of Qanadli (Qscore), Bova, and simplified Pulmonary Embolism Severity Index (sPESI) scores.

MATERIAL AND METHODS

This retrospective observational study consisted of all patients diagnosed with acute PE who were imaged under computed tomography pulmonary angiography (CTPA) for a total of 5 years between 1 June 2018 and 1 June 2023. The prediction of radiological and clinical scores for mortality and ICU admission was examined.

RESULTS

A total of 95 patients were analyzed. Patients who died and those who were admitted to the ICU had a significantly higher frequency of being found to have a high-risk (≥1) sPESI score ( = 0.04 and  = 0.016, respectively). For mortality, the sPESI score was found to be significant; the sensitivity and specificity were observed as 54% and 66% (area under the curve [AUC]=0.670, 95% confidence interval [CI]=0.527-0.814;  = 0.020). For ICU admission, the sensitivity and specificity of the Qscore, sPESI, and Bova scores were 35%, 77%, and 58%, and 78%, 65%, and 84% respectively (AUC=0.626, 95% CI=0.511-0.740,  = 0.031; AUC=0.769, 95% CI=0.674-0.865,  < 0.001; and AUC=0.767, 95% CI=0.671-0.862,  < 0.001, respectively).

CONCLUSION

It was found that the sPESI score was effective at predicting mortality in patients with acute PE. Qscore, sPESI, and Bova scores have been shown to be useful in predicting ICU admission.

摘要

背景

急性肺栓塞(PE)是一种预后严重且在急诊科死亡概率较高的疾病。

目的

研究卡纳德利(Qscore)、博瓦(Bova)和简化肺栓塞严重程度指数(sPESI)评分对PE相关死亡率和重症监护病房(ICU)收治情况的预测价值。

材料与方法

这项回顾性观察性研究纳入了2018年6月1日至2023年6月1日期间所有经计算机断层扫描肺动脉造影(CTPA)成像诊断为急性PE的患者,为期5年。研究了死亡率和ICU收治情况的影像学和临床评分预测。

结果

共分析了95例患者。死亡患者和入住ICU的患者中,高危(≥1)sPESI评分的检出频率显著更高(分别为=0.04和=0.016)。对于死亡率,sPESI评分具有显著性;观察到的敏感性和特异性分别为54%和66%(曲线下面积[AUC]=0.670,95%置信区间[CI]=0.527 - 0.814;=0.020)。对于ICU收治情况,Qscore、sPESI和Bova评分的敏感性和特异性分别为35%、77%和58%,以及78%、65%和84%(AUC=0.626,95% CI=0.511 - 0.740,=0.031;AUC=0.769,95% CI=0.674 - 0.865,<0.001;AUC=0.767,95% CI=0.671 - 0.862,<0.001)。

结论

发现sPESI评分在预测急性PE患者的死亡率方面有效。Qscore、sPESI和Bova评分已被证明在预测ICU收治情况方面有用。

相似文献

1
Prognostic performance of the Bova, sPESI, and Qanadli scores in patients with acute pulmonary embolism.Bova评分、简化肺栓塞严重性指数(sPESI)和卡纳德利(Qanadli)评分在急性肺栓塞患者中的预后评估效能
Acta Radiol. 2024 Dec;65(12):1482-1490. doi: 10.1177/02841851241289693. Epub 2024 Oct 24.
2
Performance of the Simplified Pulmonary Embolism Severity Index in predicting 30-day mortality after acute pulmonary embolism: Validation from a large-scale cohort.简化肺栓塞严重指数在预测急性肺栓塞 30 天后死亡率中的表现:来自大规模队列的验证。
Eur J Intern Med. 2024 Jun;124:46-53. doi: 10.1016/j.ejim.2024.01.037. Epub 2024 Feb 13.
3
Role of echocardiographic indicators of right ventricular dysfunction in predicting 30-day mortality in non-high- -risk patients with acute pulmonary embolism in different variants of the Bova score.在不同Bova评分变体中,右心室功能障碍的超声心动图指标在预测非高危急性肺栓塞患者30天死亡率中的作用。
Kardiol Pol. 2025;83(2):171-179. doi: 10.33963/v.phj.103453. Epub 2025 Jan 2.
4
[Predictors of adverse outcomes in patients with chronic obstructive pulmonary disease and pulmonary embolism and the predictive value of the simplified pulmonary embolism severity index].[慢性阻塞性肺疾病合并肺栓塞患者不良结局的预测因素及简化肺栓塞严重程度指数的预测价值]
Zhonghua Yi Xue Za Zhi. 2024 Nov 12;104(42):3889-3895. doi: 10.3760/cma.j.cn112137-20240603-01255.
5
Use of the National Early Warning Score for predicting deterioration of patients with acute pulmonary embolism: a post-hoc analysis of the YEARS Study.使用国家早期预警评分预测急性肺栓塞患者病情恶化: YEARS研究的事后分析
Emerg Med J. 2023 Jan;40(1):61-66. doi: 10.1136/emermed-2021-211506. Epub 2022 Nov 7.
6
Comparison of Qanadli score with conventional risk stratifiers in non-massive pulmonary emboli.非大面积肺栓塞中 Qanadli 评分与传统危险分层因子的比较。
J Int Med Res. 2024 Sep;52(9):3000605241276481. doi: 10.1177/03000605241276481.
7
Validity of mortality risk prediction scores in critically ill patients with secondary pulmonary embolism.重症继发性肺栓塞患者死亡率风险预测评分的有效性。
Biomol Biomed. 2024 Feb 28;24(4):990-997. doi: 10.17305/bb.2024.10202.
8
Predicting Hospital Survival in Patients Admitted to ICU with Pulmonary Embolism.预测入住重症监护病房的肺栓塞患者的医院生存情况。
J Intensive Care Med. 2024 May;39(5):455-464. doi: 10.1177/08850666231212875. Epub 2023 Nov 15.
9
A decision tree built with parameters obtained by computed tomographic pulmonary angiography is useful for predicting adverse outcomes in non-high-risk acute pulmonary embolism patients.计算机断层肺动脉造影获得的参数构建的决策树有助于预测非高危急性肺栓塞患者的不良结局。
Respir Res. 2019 Aug 19;20(1):187. doi: 10.1186/s12931-019-1160-5.
10
The prognostic value of pulmonary embolism severity index in acute pulmonary embolism: a meta-analysis.肺栓塞严重指数对急性肺栓塞的预后价值:一项荟萃分析。
Respir Res. 2012 Dec 4;13(1):111. doi: 10.1186/1465-9921-13-111.

引用本文的文献

1
The Role of the Pulmonary Artery Obstruction Index Ratio in Predicting the Clinical Course of Pulmonary Embolism.肺动脉阻塞指数比值在预测肺栓塞临床病程中的作用
J Clin Med. 2025 Mar 1;14(5):1673. doi: 10.3390/jcm14051673.